Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-25
1987-01-13
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514603, 514604, 514913, A61K 3141, A61K 31425, A61K 3118
Patent
active
046365150
ABSTRACT:
A topical composition for eye treatment of glaucoma, comprising a small but pharmaceutically effective amount of a non-classical carbonic anhydrase inhibitor. The most preferred compound is methyl acetazolamide. The invention also relates to a method of topically treating glaucoma with eye drops of a non-classical carbonic anhydrase inhibitor to reduce intraocular pressure.
REFERENCES:
patent: 3726892 (1973-04-01), Cebalo
patent: 4132786 (1979-01-01), Moreau et al.
patent: 4305927 (1981-12-01), Theeuwes et al.
patent: 4386098 (1983-05-01), Waltersdorf et al.
Am. J. Vet. Res. 40(3) pp. 334-345 (1979)-Gelatt et al.
J. Pharm. Exper. Therapeut. 117 pp. 385-400 (1956)-Maren.
Barfknecht Charles F.
Schoenwald Ronald D.
Robinson Douglas W.
University of Iowa Research Foundation
LandOfFree
Non-classical topical treatment for glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-classical topical treatment for glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-classical topical treatment for glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2356030